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Abstract
Ulceration is an important prognostic factor in melanoma whose biologic basis is poorly 
understood. Here we assessed the prognostic impact of pleckstrin homology domain-interacting 
protein (PHIP) copy number and its relationship to ulceration. PHIP copy number was determined 
using fluorescence in situ hybridization (FISH) in a tissue microarray cohort of 238 melanomas. 
Elevated PHIP copy number was associated with significantly reduced DMFS (P = 0.01) and DSS 
(P = 0.009) by Kaplan-Meier analyses. PHIP FISH scores were independently predictive of 
DMFS (P = 0.03) and DSS (P = 0.03). Increased PHIP copy number was an independent predictor 
of ulceration status (P = 0.04). The combined impact of increased PHIP copy number and tumor 
vascularity on ulceration status was highly significant (P< 0.0001). Stable suppression of PHIP in 
human melanoma cells resulted in significantly reduced glycolytic activity in vitro, with lower 
expression of LDH5, HIF1A, and VEGF, and was accompanied by reduced microvessel density in 
vivo. These results provide further support for PHIP as a molecular prognostic marker of 
melanoma, and reveal a significant linkage between PHIP levels and ulceration. Moreover, they 
suggest that ulceration may be driven by increased glycolysis and angiogenesis.
Introduction
Melanoma is an important clinical problem, with an estimated 76,250 new cases and 9,180 
deaths in 2012 (Siegel et al. 2012). The clinical behavior of melanoma can be unpredictable, 
making prognostic predictions difficult in individual patients. While tumor thickness 
consistently emerges as the single most significant prognostic factor determining survival, 
and while ulceration increases the risk of death within a given thickness range, additional 
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factors are required to refine the prognostic assessment of melanoma patients. Beyond 
histological factors that are reliably associated with decreased survival, molecular markers 
represent the next frontier in the evaluation of melanoma outcome. Despite the identification 
of numerous putative molecular prognostic factors, no prognostic biomarkers are routinely 
used in the evaluation of melanoma patients (Gogas et al. 2009). In addition, few biomarkers 
have been shown to retain prognostic impact, when measured on more than one platform 
(i.e., measurements at the DNA versus RNA versus protein level).
Recent studies performed by our group identified a previously unknown role for the 
pleckstrin homology domain-interacting protein (PHIP) in melanoma progression (De Semir 
et al. 2012). PHIP was identified as the top gene overexpressed in metastatic versus primary 
melanomas by gene expression profiling analysis (Haqq et al. 2005). shRNA-mediated 
suppression of PHIP resulted in significant suppression of melanoma cell invasion and 
metastatic potential in both murine and melanoma cell lines. High levels of PHIP expression 
were associated with significantly reduced survival in both mouse models and human 
tissues. Specifically, high PHIP expression (as determined by immunohistochemical 
analysis) was independently predictive of DMFS and DSS. In this study, we analyze the role 
of PHIP copy number for its prognostic significance in primary cutaneous melanoma and 
explore the linkage between PHIP levels and ulceration development in melanoma.
Results
Given the recent demonstration of a significant prognostic role for PHIP protein expression 
and the presence of elevated PHIP copy number in melanoma (De Semir et al. 2012), we 
aimed to determine the prognostic impact of PHIP copy number in primary cutaneous 
melanoma. PHIP copy number was analyzed using FISH on a TMA cohort of 238 
specimens, with known immunohistochemical analysis of PHIP protein expression, by an 
observer blinded to patient outcomes. Overall, 22% of the cohort possessed a mean copy 
number of 3 or greater. See Figure 1a for representative examples of low versus high PHIP 
copy number. As the ratio of PHIP and probes representing the centromere of chromosome 
6 in almost all of the cases was close to 1.0 (Table S1), the primary attribute assessed was 
percent of cells expressing 3 or more copies of the PHIP gene, in which there was a range 
from 0-87%, with a mean of 33.4%. There was a significant correlation between PHIP copy 
number and level of expression of the PHIP protein (P < 0.0001, Figure S1).
Initially, we analyzed the relationship between PHIP copy number and melanoma outcome 
using univariate analysis. High PHIP copy number was associated with decreased 
melanoma survival, when DMFS (P = 0.01 by log-rank test) and DSS (P= 0.009 by log-rank 
test) were assessed using Kaplan-Meier analysis (Figure 1b and 1c). In addition, there was a 
significantly increased risk of distant metastasis or death due to melanoma with the presence 
of high PHIP FISH scores. 45.4% of patients with high copy number had distant metastasis, 
when compared to 25.5% with low copy number (Fisher’s exact test, P = 0.015). 42.2% of 
patients with high copy number died of metastatic melanoma, when compared to 17.7% of 
patients with low copy number (Fisher’s exact test, P < 0.002).
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Next, we examined the relationship between PHIP copy number and survival using 
multivariate Cox regression analysis. High PHIP FISH scores were significantly predictive 
of reduced DMFS (P = 0.03, Table 1) and DSS (P = 0.027, Table 2) in multivariate models 
that included tumor thickness, ulceration, age, gender, and tumor site. Thus, PHIP copy 
number was independently predictive of survival associated with melanoma, similar to the 
results obtained for PHIP protein expression (De Semir et al. 2012).
Recently, high PHIP immunohistochemical scores were shown to correlate with ulceration 
status (De Semir et al. 2012). We aimed to confirm this relationship at the DNA level. High 
PHIP copy number was significantly associated with ulceration status when analyzed by 
univariate logistic regression analysis (P=0.004). In addition, high PHIP copy number was 
associated with a significantly increased risk of developing ulceration. Thus, ulceration was 
present in 45.5% of cases with high PHIP copy number, when compared with 28.8% of 
cases with low PHIP copy number (P = 0.013, Fisher’s exact test).
Previously, we reported that ulceration was associated with increased tumor vascularity in 
the primary tumor, when assessed morphologically (Kashani-Sabet et al. 2002). Elevated 
tumor vascularity (as determined by melanomas with prominent versus all lower degrees of 
vascularity) was significantly associated with ulceration status. Ulceration was present in 
60.3% of the cases with prominent tumor vascularity, when compared with 22.2% of cases 
with lower degrees of tumor vascularity (P < 0.0001, Fisher’s exact test). This served to 
confirm the previously reported results in this tissue microarray cohort. We then explored 
the combined impact of high PHIP copy number and elevated tumor vascularity on the 
development of ulceration. Ulceration was present in 20.2% of melanomas with both low 
PHIP copy number and low tumor vascularity. This increased to 38.8% of cases ulcerated 
with either prognostic factor elevated, and to 72.2% of melanomas ulcerated, when both 
factors were elevated (P < 0.0001, Chi-square test of percentage differences).
We then assessed the relationship between PHIP copy number and ulceration status, using 
multivariate logistic regression analysis. Presence of ulceration in melanoma is also known 
to increase both with increasing tumor thickness and with increasing mitotic rate (Balch et 
al. 2001b; Thompson et al. 2011). A multivariate logistic regression analysis was performed, 
including low versus high PHIP copy number, low versus high tumor vascularity, tumor 
thickness, and mitotic rate. All four factors were significantly predictive of the incidence of 
ulceration (Table 3). Thus, PHIP FISH scores were independently predictive of ulceration 
status, even with the inclusion of these other factors (P = 0.04).
Next, we explored cellular pathways regulated by PHIP expression potentially relevant to 
the development of ulceration. Targeted suppression of PHIP (using an anti-PHIP shRNA) 
in C8161.9 human melanoma cells (with elevated PHIP copy number) was previously 
shown to significantly suppress melanoma cell invasiveness and metastatic potential (De 
Semir et al. 2012). Given that PHIP functions in the IGF1R pathway that is important in 
regulating glucose metabolism, we assessed whether suppression of PHIP activity resulted 
in altered glycolytic activity of melanoma cells. C8161.9 cells expressing the anti-PHIP 
shRNA produced significantly lower amounts of lactate than control cells expressing a 
shRNA targeting luciferase (anti-luc shRNA) (Figure 2a). This was associated with 
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decreased expression of LDH5, the most efficient isoenzyme of lactate dehydrogenase, 
which catalyzes the conversion of pyruvate to lactate in the final step of glycolysis (Figure 
2b). In addition, culturing anti-PHIP shRNA-expressing cells in the presence of 
methylpyruvate, which bypasses glycolysis and directly enters the Krebs cycle, resulted in 
significantly increased invasion (Figure 2c). Thus, the proinvasive role of PHIP in 
melanoma is mediated, at least in part, by activating the glycolytic pathway. Moreover, 
C8161.9 melanoma cells with reduced PHIP expression produced lower levels of VEGF, as 
determined by an ELISA assay of human VEGF secretion (Figure 2d). As VEGF expression 
is controlled by HIF1A (Forsythe et al. 1996), melanoma cells with suppressed PHIP 
expression were also shown to express lower levels of HIF1A by Western analysis (Figure 
2b).
Finally, we assessed the effects of suppression of PHIP on the angiogenic potential of 
human melanoma cells in vivo. C8161.9 melanoma cells were inoculated subcutaneously 
into nude mice, and the resultant tumors examined for microvessel density using 
immunofluorescence of CD31 positivity. While there was no significant difference in the 
tumor volume between the two groups (data not shown), tumors in the anti-PHIP shRNA-
expressing group (Figure 3a, right panel) exhibited large areas of necrosis when compared 
with the control group (Figure 3a, left panel). Analysis of CD31 expression revealed that the 
control tumors were characterized by large, abnormal blood vessels and hemorrhage, 
apparent from autofluorescence of erythrocytes and lipofuscin (Baschong et al. 2001) 
(Figure 3b and 3c, left panels). By contrast, the vessels in the anti-PHIP shRNA-expressing 
tumors were smaller, with little or no hemorrhage evident (Figure 3b and 3c, right panels). 
Finally, the anti-PHIP shRNA-expressing tumors had significantly reduced microvessel 
density when compared with the control tumors (P < 0.02 as assessed both by a T test and 
by a two-sample randomization test, Figure 3d). Thus, increasing PHIP expression in human 
melanoma cells promotes angiogenic potential.
Discussion
In this manuscript, we describe a previously unreported role for PHIP copy number in the 
prognosis associated with melanoma. PHIP FISH scores were predictive of a significantly 
increased risk of both distant metastasis and death due to melanoma, and were 
independently predictive of DMFS and DSS. In addition, elevated PHIP FISH scores were 
associated with a higher incidence of ulceration and were independently predictive of 
ulceration status. The combined impact of PHIP copy number and tumor vascularity was 
additive, as cases with high levels of both factors had a significantly higher incidence of 
ulceration than cases with low levels of either or both factors. Finally, C8161.9 human 
melanoma cells with suppressed PHIP expression exhibited reduced glycolytic activity and 
angiogenic potential.
These results provide further support for the role of PHIP as a molecular prognostic marker 
for melanoma, as initially described using immunohistochemical analysis of PHIP 
expression. High PHIP protein expression was associated with a significantly increased risk 
of distant metastasis and death due to melanoma, and was independently predictive of 
DMFS and DSS (De Semir et al. 2012). Our analysis of PHIP copy number parallels the 
Bezrookove et al. Page 4
J Invest Dermatol. Author manuscript; available in PMC 2014 September 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
results obtained in human and murine melanoma cell lines, in which suppressed PHIP 
expression resulted in significantly reduced metastatic potential and increased survival in 
xenograft models.
To date, few markers have been shown to provide significant prognostic impact in 
melanoma when assessed on more than one platform. For example, SPP1 expression has 
been shown to have independent prognostic significance when assessed at the RNA and 
protein levels (Rangel et al. 2008; Conway et al. 2009). Our studies have demonstrated a 
significant prognostic role for PHIP at both the DNA and protein levels. Although the ratio 
of PHIP to chromosome 6 centromeric probe was close to 1.0 in the great majority of cases 
examined, changes in PHIP copy number, ranging from euploidy to 3 or greater copies, 
were highly correlated with increased PHIP expression. Additional studies of PHIP levels 
will be required in distinct cohorts in order to further validate its prognostic role.
Beyond an independent impact on survival, these studies confirmed a significant and 
independent relationship between PHIP levels and ulceration status. In addition, PHIP copy 
number combined dramatically with tumor vascularity to increase the incidence of 
ulceration in primary melanoma specimens. Ulceration is an important prognostic factor that 
has been incorporated into the AJCC staging classification for melanoma for over a decade 
(Balch et al. 2001a, 2009). More recently, ulceration has been suggested as a potential 
predictive marker of benefit to adjuvant interferon alpha therapy (McMasters et al. 2010; 
Eggermont et al. 2012). However, the biologic basis for the development of ulceration is 
poorly understood.
Increasing incidence of ulceration in melanoma is associated with increasing tumor 
thickness, mitotic rate, and tumor vascularity (Balch et al. 2001b; Thompson et al. 2011). In 
addition, gene expression profiling studies have identified a gene signature that correlates 
with ulceration (Winnepenninckx et al. 2006). However, the specific cellular pathways and 
mechanisms by which ulceration develops are unclear. The linkage between PHIP levels and 
ulceration implies a role for the IGF1R pathway in ulceration, given PHIP’s involvement in 
this signal transduction pathway. In addition, our studies in human melanoma cells 
demonstrating that downregulation of PHIP expression results in significantly reduced 
glycolytic activity, VEGF secretion, and microvessel density provide mechanistic insights, 
identifying glucose metabolism and tumor angiogenesis as pathways by which ulceration 
may develop in melanoma.
Tumor cell growth is promoted by increased glucose consumption, a phenomenon known as 
the Warburg effect (Warburg 1956). The importance of glycolysis to melanoma progression 
has been amply reported in melanoma cell lines (Halaban et al. 1997, 2002; Bagheri et al. 
2006) and is demonstrated clinically by the utility of PET scanning in the radiologic 
assessment of melanoma both during initial staging (Reinhardt et al. 2006; Falk et al. 2007) 
and in response to targeted therapy (McArthur et al. 2012). Glycolysis in tumor cells is 
driven by AKT (Elstrom et al. 2004), and PHIP is a potent activator of AKT in melanoma 
(De Semir et al. 2012). Moreover, increased glucose metabolism can itself drive tumor 
angiogenesis, invasion, and metastasis (Lay et al. 2000; Tsutsumi et al. 2004). Thus, our 
studies on PHIP in melanoma describe a previously unreported link between PHIP, the 
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Warburg effect, tumor angiogenesis, and ulceration development. As PHIP is activated 
through increased copy number in a subset of melanomas, additional markers of ulceration 
will need to be identified in melanomas without PHIP activation. However, the mechanistic 
analyses provided here should facilitate the identification of these additional markers in 
distinct molecular subsets of melanoma patients.
Finally, our investigation of PHIP in melanoma tissues and cell lines suggests an intriguing 
link between ulceration and LDH levels. These results imply that a common tumor-
promoting pathway (i.e., IGF1R), resulting in increased glycolysis, may underlie the 
biologic basis of two prominent prognostic markers incorporated into the AJCC staging 
classification, one that refines the prognosis of localized melanoma, the other the prognosis 
of disseminated melanoma. Elevated LDH5 expression in primary melanoma has been 
previously shown to be associated with reduced survival on univariate analysis, but was not 
independently predictive of melanoma outcome (Zhuang et al. 2010). Furthermore, LDH 
activity has been correlated to HIF1A expression and angiogenic potential (Koukourakis et 
al. 2003). However, further studies will be required in order to confirm the link between 
ulceration and LDH levels suggested by this analysis. In addition, high levels of 
angiopoietin-2 have been reported in multiple cancers, with a possible prognostic role 
(Bonner and Arbiser 2012), and are accompanied by upregulation of RAC signaling 
pathways (Felcht et al. 2012). Thus, it is possible that elevated PHIP copy number can 
modulate angiopoietin levels in melanoma, in part through mitrochondrial dysfunction, 
NADPH oxidase induction, and increased generation of reactive oxygen species (which 
result in angiopoietin-2 activation). In conclusion, our studies support an important role for 
PHIP as a molecular marker of melanoma ulceration, metastasis and survival, and provide 
insights into the cellular pathways through which ulceration can develop.
Materials and methods
Study population
This study used a tissue microarray cohort that was previously described according to 
REMARK guidelines (Rangel et al. 2006; Kashani-Sabet et al. 2009). The molecular 
prognostic factor analyses performed herein were approved by the appropriate ethics boards 
both at CPMC and UCSF.
Fluorescence in situ hybridization (FISH)
FISH was performed as previously described (Wiegant and Raap 2001; Chin et al. 2003; De 
Semir et al. 2012) using BAC clones RP11-767O1, RP11-484L10, RP11-217L13 and 
CTD-2297E14 to detect the PHIP locus and clones RP11-26M18 and RP11-136K2 to detect 
6q11.1 and 6p11.1 respectively (February 2009 freeze of the UCSC Genome Browser, 
http://genome.ucsc.edu). BAC DNA’s were prepared with the Large-Construct kit (Qiagen, 
Valencia, CA) and labeled by nick translation with Alexa Fluor 488 and 594 dUTP’s (Life 
Technologies, Grand Island, NY) as described (Wiegant and Raap 2001). The quality and 
mapping of all probes were verified by hybridization to normal metaphase spreads in 
combination with a commercially available centromeric probe for chromosome 6 (Open 
Biosystems, Lafayette, CO) before tissue analysis. Hybridization on TMA’s was performed 
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as described previously (Wiegant and Raap 2001; Chin et al. 2003). Images were taken with 
a Zeiss Axio Imager Z2 controlled by AxioVision software. The FISH signals were assessed 
and counted manually from images with several Z stack layers acquired using a Zeiss Axio 
Image Z2 microscope controlled by AxioVision software (Zeiss, Jena,Germany). At least 30 
nuclei from each case were evaluated, and the signals were interpreted according to 
guidelines described previously (Bayani and Squire 2004) and recorded as 1 through 5 or 
greater. Signals from BAC clones detecting 6q11.1 and 6p11.1 were interpreted as the 
centromeric signal for chromosome 6 and the count was used as control.
Cell culture studies
C8161.9 human melanoma cells stably expressing anti-PHIP shRNA and anti-luciferase 
(anti-luc) shRNA were generated and propagated as described (De Semir et al. 2012). 
Lactate production and invasion into matrigel were assayed as reported (De Semir et al. 
2012). C8161.9 cells were treated with 10 mM methylpyruvate (Sigma, St. Louis, MO.) for 
48 hours before the invasion assay. VEGF secretion was measured by using an ELISA kit 
following the manufacturer’s instructions (DY293B, R&D Systems Inc, Minneapolis, MN). 
Western blotting was performed as described using antibodies targeting HIF1A (ab16066, 
Abcam, Minneapolis, MN), LDH5 (ab1015, Abcam) and GAPDH (MAB374, Millipore, 
Billerica, MA).
Immunofluorescence
Groups of 6 nu/nu mice were inoculated subcutaneously with 1 million C8161.9 human 
melanoma cells expressing either control luc or anti-PHIP shRNA. On day 25, the mice 
were euthanized and the tumors were assessed for microvessel density based on CD31 
positivity by immunofluorescence, which was performed using a rabbit anti-CD31 antibody 
(ab28364, Abcam) and a secondary antibody labeled with Alexa Fluor 594 (Life 
Technologies) as described previously (Jalas et al. 2011). Mosaic images were acquired with 
20X magnification at a fixed exposure with a Zeiss Axio Imager Z2 microscope controlled 
by AxioVision software. After automatically stitching the images, the number of CD31 
positive objects and area were determined using ImageJ software. The number of CD31 
positive vessels was quantitated and the microvessel density reported as the total CD31 
count over the entire area of the tumor.
Statistical Analysis
Statistical methods used to assess the significance of various prognostic factors on 
melanoma outcome were previously described (Rangel et al. 2006; Kashani-Sabet et al. 
2009). The coding for clinical or pathological attributes was performed as described by the 
AJCC staging committee for melanoma (Balch et al. 2001b). The correlation between PHIP 
copy number and immunohistochemical score was tested by regression analysis using Data 
Desk software. For both DMFS and DSS, the definition of high PHIP FISH scores, as 
measured by percentage of cells harboring 3 or more copies of PHIP, was established as 
equal to or greater than 16%. A 16% cutoff served to maximize the average of the sensitivity 
and specificity in the prediction of both DMFS and DSS, analyzed separately. The same 
16% cutoff was then uniformly and consistently used in all subsequent analyses of DMFS 
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and DSS. The association between high PHIP copy number and DMFS or DSS was assessed 
using both Kaplan-Meier analysis and multivariate Cox regression. The association between 
high PHIP copy number and presence or absence of ulceration was assessed using both 
Fisher’s exact test and multivariate logistic regression analysis. The association between a 
high degree of tumor vascularity and ulceration was also assessed using both Fisher’s exact 
test and multivariate logistic regression. Assessment of the differential impacts of neither, 
either, and both of these two factors was done using both Chi-square analysis and Fisher’s 
exact test. In predicting ulceration status, high PHIP copy number was uniformly defined as 
greater than or equal to 35% of tumor cells harboring 3 or more copies of the PHIP gene. 
This cutoff was similarly selected as the one that maximized the average of sensitivity and 
specificity in predicting ulceration. All P values reported are two-sided.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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PHIP pleckstrin homology domain-interacting protein
FISH fluorescence in situ hybridization
DMFS distant metastasis-free survival
DSS disease-specific survival
LDH5 Lactate dehydrogenase 5
VEGF vascular endothelial growth factor
HIF1A hypoxia inducible factor 1 alpha subunit
TMA tissue microarray
shRNA short hairpin RNA
CD31 cluster of differentiation 31
BAC bacterial artificial chromosome
ELISA Enzyme-Linked ImmunoSorbent Assay
IGF1R insulin-like growth factor 1 receptor
RAC RAS-related C3 botulinum toxin substrate
TIE receptor tyrosine kinase epithelial-specific
NADPH oxidase nicotinamide adenine dinucleotide phosphate-oxidase
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Figure 1. 
PHIP copy number and its correlation with DMFS and DSS in melanoma patients. (a) Dual 
color FISH for PHIP locus, red, and centromere of chromosome 6, green, representative of 
low PHIP copy number, left panel, and high copy number, right panel. Scale bar = 20 Rm. 
(b) Kaplan-Meier analysis of DMFS in patients with low PHIP copy number (curve 1) 
versus patients with high PHIP copy number (curve 2). (c) Kaplan-Meier analysis of DSS in 
patients with low PHIP copy number (curve 1) versus patients with high PHIP copy number 
(curve 2).
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Figure 2. 
Effects of shRNA-mediated suppression of PHIP in human melanoma cells. (a) Lactate 
production in C8161.9 cells expressing anti-PHIP shRNA versus control cells expressing 
anti-luc shRNA. Mean ± SE; N = 3. * denotes P < 0.003. (b) Western analysis of LDH5 and 
HIF1A in C8161.9 cells expressing anti-luc shRNA (control cells, lane 1) or anti-PHIP 
shRNA (lane 2). (c) Invasive capacity of C8161.9 stable transformants expressing anti-PHIP 
shRNA with or without the addition of methylpyruvate (MP). Mean ± SE; N = 3. * denotes 
P < 0.05. (d) ELISA assay of human VEGF levels produced by C8161.9 cells expressing 
anti-PHIP shRNA versus control cells expressing anti-luc shRNA. Mean ± SE; N = 3. * 
denotes P < 0.0001.
Bezrookove et al. Page 12
J Invest Dermatol. Author manuscript; available in PMC 2014 September 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 3. 
Effects of PHIP expression on the angiogenic potential of C8161.9 human melanoma cells 
in vivo. (a) Representative images of H&E staining of subcutaneous tumors in nude mice. 
The left panel shows the growth pattern of C8161.9 cells expressing anti-luc shRNA, 
compared with C8161.9 cells expressing anti-PHIP shRNA (right panel). (b) Composite 
images of immunofluorescence detection of CD31, red, and DAPI, blue as counterstain. The 
left panel shows the staining pattern of CD31 in subcutaneous tumor with C8161.9 cells 
expressing anti-luc shRNA compared with C8161.9 cells expressing anti-PHIP shRNA 
(right panel). Scale bar = 100 Rm. (c) Composite images of CD31 staining pattern with 
higher magnification for tumors with C8161.9 cells expressing anti-luc shRNA (left panel), 
or anti-PHIP shRNA (right panel). Scale bar = 20 Rm. (d) Quantification of microvessel 
density (MVD) based on CD31 immunofluorescence positivity in tumors (six per group) 
with C8161.9 cells expressing either anti-luc shRNA or anti-PHIP shRNA. Mean ± SD. * 
denotes P < 0.02.
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Table 1
Cox regression analysis of impact of various prognostic factors on DMFS of melanoma cohort (N = 231).
Prognostic factor Chi-square Risk Ratio P value
Tumor thickness 6.96 1.38 .008
High PHIP copy number 4.73 1.99 .03
Ulceration 3.31 1.51 .07
Sex 1.41 1.34 .24
Site 0.92 1.24 .34
Age 0.61 0.95 .44
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Table 2
Cox regression analysis of impact of various prognostic factors on DSS of melanoma cohort (N = 231).
Prognostic factor Chi-square Risk Ratio P value
Tumor thickness 6.13 1.38 .013
High PHIP copy number 4.87 2.21 .027
Ulceration 3.63 1.58 .057
Sex 1.00 1.30 .32
Site 0.81 1.24 .37
Age 0.01 0.99 .91
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Table 3
Logistic regression analysis of impact of various prognostic factors on incidence of ulceration in melanoma 
cohort (N = 228).
Prognostic factor Chi-square Odds Ratio P value
Mitotic rate 15.24 1.23 .0001
Tumor vascularity 10.26 3.05 .001
Tumor thickness 5.99 1.63 .01
High PHIP copy number 4.10 1.96 .04
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